Literature DB >> 22996099

The utility of uterine artery Doppler velocimetry in prediction of preeclampsia in a low-risk population.

Leslie Myatt1, Rebecca G Clifton, James M Roberts, Catherine Y Spong, John C Hauth, Michael W Varner, Ronald J Wapner, John M Thorp, Brian M Mercer, William A Grobman, Susan M Ramin, Marshall W Carpenter, Philip Samuels, Anthony Sciscione, Margaret Harper, Jorge E Tolosa, George Saade, Yoram Sorokin, Garland D Anderson.   

Abstract

OBJECTIVE: The underlying pathophysiology of preeclampsia is thought to be abnormal trophoblast invasion of the spiral arteries leading to maldevelopment of uteroplacental perfusion. We estimated whether uterine artery Doppler measurements made in the early second trimester would predict the subsequent development of preeclampsia.
METHODS: Uterine artery Doppler measurements before 21 weeks of gestation (median 16.6 weeks) were correlated with subsequent development of preeclampsia in a cohort of 2,188 low-risk nulliparous women in a randomized control trial of antioxidant supplementation for prevention of preeclampsia. Preeclampsia developed in 165 (7.5%) women.
RESULTS: Development of preeclampsia overall was associated with increased resistance index, pulsatility index, a pulsatility index or resistance index multiple of the median at or above the 75th percentile but not the presence of a notch or a bilateral notch before 21 weeks of gestation. The sensitivity was 43% (95% confidence interval [CI] 35-51) and specificity 67% (95% CI 65-69) for prediction of preeclampsia overall. The presence of a notch or bilateral notch, resistance index, and pulsatility index multiple of the median was significantly associated with early onset (before 34 weeks of gestation) compared with late onset or no preeclampsia (odds ratio [OR] 6.9, 95% CI 2.3-20.9; sensitivity 78%, 95% CI 52-94; specificity 66%, 95% CI 64-68). The presence of a notch or resistance index multiple of the median at or above the 75th percentile increased the odds of developing severe compared with mild or no preeclampsia (OR 2.2, 95% CI 1.4-3.7; sensitivity 53%, 95% CI 40-65; specificity 66%, 95% CI 64-68).
CONCLUSION: Our data show poor sensitivity of second-trimester Doppler ultrasound measurements for prediction of preeclampsia overall in a well-characterized, low-risk, nulliparous population. The technique has utility in identifying poor trophoblast invasion of spiral arteries of a magnitude that severely compromises uteroplacental blood flow and gives early-onset disease. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Year:  2012        PMID: 22996099      PMCID: PMC3449210          DOI: 10.1097/AOG.0b013e31826af7fb

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  19 in total

1.  Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation.

Authors:  A M Martin; R Bindra; P Curcio; S Cicero; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  2001-12       Impact factor: 7.299

Review 2.  The role of uterine artery Doppler in predicting adverse pregnancy outcome.

Authors:  Aris T Papageorghiou; Christina K H Yu; Kypros H Nicolaides
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2004-06       Impact factor: 5.237

3.  Predicting and preventing pre-eclampsia-where to next?

Authors:  A T Papageorghiou
Journal:  Ultrasound Obstet Gynecol       Date:  2008-04       Impact factor: 7.299

4.  New doppler technique for assessing uteroplacental blood flow.

Authors:  S Campbell; J Diaz-Recasens; D R Griffin; T E Cohen-Overbeek; J M Pearce; K Willson; M J Teague
Journal:  Lancet       Date:  1983-03-26       Impact factor: 79.321

5.  First-trimester prediction of preeclampsia in nulliparous women at low risk.

Authors:  Leslie Myatt; Rebecca G Clifton; James M Roberts; Catherine Y Spong; John C Hauth; Michael W Varner; John M Thorp; Brian M Mercer; Alan M Peaceman; Susan M Ramin; Marshall W Carpenter; Jay D Iams; Anthony Sciscione; Margaret Harper; Jorge E Tolosa; George Saade; Yoram Sorokin; Garland D Anderson
Journal:  Obstet Gynecol       Date:  2012-06       Impact factor: 7.661

6.  The two stage model of preeclampsia: variations on the theme.

Authors:  J M Roberts; C A Hubel
Journal:  Placenta       Date:  2008-12-13       Impact factor: 3.481

7.  Uterine artery Doppler velocimetry in pregnant women with hypertension.

Authors:  A Fleischer; H Schulman; G Farmakides; L Bracero; L Grunfeld; B Rochelson; M Koenigsberg
Journal:  Am J Obstet Gynecol       Date:  1986-04       Impact factor: 8.661

8.  Uterine artery Doppler at 11 + 0 to 13 + 6 weeks and 21 + 0 to 24 + 6 weeks in the prediction of pre-eclampsia.

Authors:  W Plasencia; N Maiz; L Poon; C Yu; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  2008-08       Impact factor: 7.299

Review 9.  Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review.

Authors:  Yves Giguère; Marc Charland; Emmanuel Bujold; Nathalie Bernard; Sonya Grenier; François Rousseau; Julie Lafond; France Légaré; Jean-Claude Forest
Journal:  Clin Chem       Date:  2009-12-31       Impact factor: 8.327

Review 10.  Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses.

Authors:  Sarah D McDonald; Ann Malinowski; Qi Zhou; Salim Yusuf; Philip J Devereaux
Journal:  Am Heart J       Date:  2008-10-02       Impact factor: 4.749

View more
  20 in total

1.  Cell-Free Total and Fetal DNA in First Trimester Maternal Serum and Subsequent Development of Preeclampsia.

Authors:  Robert M Silver; Leslie Myatt; John C Hauth; Kenneth J Leveno; Alan M Peaceman; Susan M Ramin; Philip Samuels; George Saade; Yoram Sorokin; Rebecca G Clifton; Uma M Reddy
Journal:  Am J Perinatol       Date:  2016-07-11       Impact factor: 1.862

2.  Predictive accuracy of the first trimester Doppler scan: a meta-study.

Authors:  Naira Roland Matevosyan
Journal:  Wien Med Wochenschr       Date:  2015-06-16

Review 3.  Emerging role for dysregulated decidualization in the genesis of preeclampsia.

Authors:  Kirk P Conrad; Maria Belen Rabaglino; Emiel D Post Uiterweer
Journal:  Placenta       Date:  2017-06-09       Impact factor: 3.481

Review 4.  Prediction of preeclampsia-bench to bedside.

Authors:  Anjali Acharya; Wunnie Brima; Shivakanth Burugu; Tanvi Rege
Journal:  Curr Hypertens Rep       Date:  2014-11       Impact factor: 5.369

5.  Gestational hypoxia induces preeclampsia-like symptoms via heightened endothelin-1 signaling in pregnant rats.

Authors:  Jianjun Zhou; Daliao Xiao; Yali Hu; Zhiqun Wang; Alexandra Paradis; Eugenia Mata-Greenwood; Lubo Zhang
Journal:  Hypertension       Date:  2013-07-01       Impact factor: 10.190

6.  Haptoglobin phenotype and abnormal uterine artery Doppler in a racially diverse cohort.

Authors:  Tracey L Weissgerber; Paula L McGee; Leslie Myatt; John C Hauth; Michael W Varner; Ronald J Wapner; John M Thorp; Brian M Mercer; Alan M Peaceman; Susan M Ramin; Philip Samuels; Anthony C Sciscione; Margaret Harper; George Saade; Yoram Sorokin
Journal:  J Matern Fetal Neonatal Med       Date:  2014-01-13

Review 7.  Subtypes of Preeclampsia: Recognition and Determining Clinical Usefulness.

Authors:  James M Roberts; Janet W Rich-Edwards; Thomas F McElrath; Lana Garmire; Leslie Myatt
Journal:  Hypertension       Date:  2021-03-29       Impact factor: 10.190

8.  Combination of PAPPA, fhCGβ, AFP, PlGF, sTNFR1, and Maternal Characteristics in Prediction of Early-onset Preeclampsia.

Authors:  Anna Yliniemi; Kaarin Makikallio; Teemu Korpimaki; Heikki Kouru; Jaana Marttala; Markku Ryynanen
Journal:  Clin Med Insights Reprod Health       Date:  2015-06-11

9.  Doppler ultrasound evaluation in preeclampsia.

Authors:  Maria A Lopez-Mendez; Victoria Martinez-Gaytan; Raul Cortes-Flores; Rene M Ramos-Gonzalez; Mauro A Ochoa-Torres; Idalia Garza-Veloz; Monica I Martinez-Acuña; Jose I Badillo-Almaraz; Margarita L Martinez-Fierro
Journal:  BMC Res Notes       Date:  2013-11-19

10.  Gene expression profiling of pre-eclamptic placentae by RNA sequencing.

Authors:  Tea Kaartokallio; Alejandra Cervera; Anjuska Kyllönen; Krista Laivuori; Juha Kere; Hannele Laivuori
Journal:  Sci Rep       Date:  2015-09-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.